UCSD, astronauts test new cancer-fighting drug in space
Scientists from UCSD's Sanford Stem Cell Institute are working in collaboration with Axiom Space and the JM Foundation on the research project called Cancer in LEO-3, which aims to test how cancer cells behave in response to radiation and microgravity in low Earth orbit (LEO).
Catriona Jamieson, M.D., Ph.D. at the Sanford Stem Cell Clinical Center at UCSD Medical Center in La Jolla, is the primary investigator on the project, in partnership with researcher Jessica Pham.
San Diego Scripps scientist competes in Netflix's 'All the Sharks' reality show
The study focuses on the anti-cancer drug 'rebecsinib' which was developed by Dr. Jamieson and her lab. Researchers say rebecsinib has the potential to fight 23 different types of cancer.
The drug launched into space for further testing aboard a SpaceX Dragon spacecraft and SpaceX Falcon 9 rocket on Axiom Space's Ax-4 mission on Wednesday, June 11.
On Axiom Space's previous mission, Ax-3, the new drug acted as a 'kill switch' by stopping the growth of 'ADAR1-expressing breast cancer organoids,' according to researchers.
During the current mission, Ax-4, astronauts on the International Space Station will test how rebecsinib affects tumor organoids derived from cancer stem cells related to leukemia, ovarian cancer, metastatic breast cancer and glioblastoma multiforme.
The Ax-4 crew includes astronauts from India, Poland and Hungary. According to Axiom Space, the mission marks each nation's first trip to space in over 40 years.
Peggy Whitson from the U.S. serves as commander on the Ax-4 mission. She is accompanied by Shubhanshu Shukla, an Indian Air Force pilot, and mission specialists Slawosz Uznanski-Wisniewski from Poland, and Tibor Kapu from Hungary.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
Gluco6 Recognized for Strong Ingredient Transparency and OTC GLUT-4 Nutritional Support
AUSTIN, July 03, 2025 (GLOBE NEWSWIRE) — SECTION 1 – INTRODUCTION As interest in blood sugar health continues to expand across both clinical and non-clinical audiences, consumers are increasingly turning to nutrition science for new pathways to glucose management. Search trends show a growing curiosity in natural approaches to support healthy glucose levels, with a notable emphasis on metabolic flexibility, energy balance, and insulin sensitivity. In 2025, keywords such as 'natural blood sugar support,' 'GLUT-4 receptor,' and 'glucose stability' have gained momentum across digital wellness communities, reflecting a broader shift away from purely pharmaceutical solutions. The challenges of maintaining balanced blood sugar have become a frequent topic in wellness forums, with individuals expressing concerns around post-meal energy crashes, insulin spikes, and fatigue. At the same time, attention has turned to the underlying mechanisms—such as GLUT-4 receptor activity and metabolic responsiveness—as potential targets for support through diet and lifestyle. This shift has driven interest in ingredient-based interventions that are free of synthetic compounds, caffeine, or habit-forming additives. In response to this emerging demand, non-synthetic formulations with scientifically recognized plant-based ingredients have begun to gain visibility. Positioned at the intersection of transparency, innovation, and holistic health, Gluco6 represents part of this evolution in how the market approaches nutritional support for blood sugar metabolism. Further details about the formulation and ingredient sourcing can be found on the official informational platform SECTION 2 – PRODUCT/COMPANY UPDATE Gluco6, a plant-based glucose support formula, has released its latest ingredient update and formulation positioning for 2025, aligned with evolving consumer awareness around GLUT-4 receptor activity and non-synthetic pathways for managing blood sugar fluctuations. The formula, originally introduced as part of a broader push toward integrative glucose balance, now emphasizes its focus on GLUT-4 modulation—a mechanism supported by a growing body of nutritional and academic research. Unlike conventional formulations that often rely on stimulants or short-term glycemic suppression, Gluco6 positions itself as a wellness-aligned system built around the regulation of glucose transport pathways. At the center of this formula is Sukre™, a functional compound featured for its supportive interaction with GLUT-4 receptors, which play a critical role in the transport of glucose into muscle and fat cells. The 2025 update clarifies that Gluco6 is not intended to treat or cure any medical condition but serves as an informational approach to exploring non-clinical nutritional support. Developed without genetically modified ingredients, artificial stimulants, or synthetic additives, the Gluco6 formula also incorporates a blend of Mediterranean-sourced botanicals and micronutrients. The goal is to address consumer interest in formulations that prioritize purity, sustainability, and accessibility, without requiring prescription intervention. As of 2025, Gluco6 has expanded public-facing documentation to reinforce transparency in sourcing, ingredient disclosure, and alignment with trends in clean-label supplement development. The product update also includes a reaffirmation of the company's neutral wellness positioning—focusing on how nutritional strategies may support the body's natural glucose metabolism without implying outcomes or clinical effects. This update reflects Gluco6's continued alignment with current consumer behavior: seeking proactive, educational, and ingredient-based approaches to metabolic health. SECTION 3 – CONSUMER TREND OVERVIEW Throughout 2024 and into 2025, online search trends related to blood sugar balance have increasingly favored terms rooted in lifestyle wellness and plant-based support. Interest in phrases such as 'GLUT-4 function,' 'natural glucose regulation,' and 'non-synthetic blood sugar supplement' has reflected a cultural pivot toward metabolic autonomy—where individuals seek solutions that align with personal health goals without relying solely on pharmaceutical interventions. Public forums and wellness communities have observed a notable increase in discussions surrounding the mechanisms that influence glucose uptake, including insulin sensitivity, cellular transport pathways, and the role of nutrient timing. Central to these conversations is the GLUT-4 receptor, a protein that facilitates the movement of glucose into cells and has become a focal point for metabolic research and consumer inquiry alike. Gluco6's emergence into this environment corresponds with these heightened awareness levels. Rather than offering direct claims or prescriptive messaging, Gluco6 aligns with the growing preference for ingredient transparency and educational framing. Its inclusion of GLUT-4-supportive elements responds to the elevated attention this receptor has received in peer-reviewed studies and lifestyle research. In particular, consumers seeking to stabilize energy levels throughout the day—without the highs and lows associated with unregulated blood sugar—have shown interest in formulas that integrate metabolic adaptogens, antioxidant-rich botanicals, and bioavailable nutrients. These consumers often express a desire for plant-based formulations that can fit into daily routines without dependency or disruption. Gluco6's update positions the product within this narrative, offering a formulation that speaks to educated buyers interested in the intersection between nutritional science and non-clinical wellness. As digital content around metabolic flexibility and insulin response continues to rise, products that approach glucose management from a holistic, research-aware standpoint are seeing increased visibility in search engines and across peer-led platforms. To explore the full ingredient profile and supporting documentation, visit the official Gluco6 resource page. SECTION 4 – INGREDIENT SPOTLIGHT The Gluco6 formulation is centered around six ingredients selected for their alignment with contemporary wellness discussions surrounding non-synthetic blood sugar support. Each ingredient in the formula has been highlighted in academic literature or traditional nutrition systems for its potential to interact with metabolic processes in a non-clinical, supportive capacity. Sukre™ Sukre is positioned as a functional compound designed to work in harmony with the body's GLUT-4 transport mechanisms. As public interest grows around the role of cellular glucose transporters, Sukre has been referenced in emerging nutrition science as a compound that may complement healthy metabolic signaling. Gluco6 emphasizes Sukre as a core feature of its non-synthetic positioning, distinguishing it from traditional glucose-lowering agents that rely on acute suppression. TeaCrine® (Theacrine) Derived from Chinese tea leaves, TeaCrine is included in the Gluco6 formulation as a source of non-stimulant plant alkaloids. In various nutrition-focused publications, TeaCrine has been explored for its relationship with energy and focus without the involvement of caffeine. While not intended to produce clinical outcomes, its inclusion supports interest in plant-derived adaptogens. Gymnema Sylvestre A botanical with longstanding traditional use, Gymnema has been studied for its interaction with glucose perception and dietary habits. Often featured in educational content surrounding carbohydrate metabolism, Gymnema's presence in Gluco6 reflects a broader return to botanical heritage within modern supplement design. Chromium Recognized as an essential trace element, Chromium has been frequently mentioned in relation to insulin sensitivity and glycemic balance in nutrition science. Gluco6 includes Chromium in a bioavailable form, underscoring its role in contributing to foundational metabolic processes without overstating its role in therapeutic interventions. Cinnamon Bark Extract Used widely in culinary traditions and increasingly discussed in wellness circles, Cinnamon is incorporated in Gluco6 due to its relevance in insulin receptor support discussions. Its presence in the formula supports the theme of using accessible, food-sourced compounds within structured supplement protocols. Green Tea Extract Green Tea contributes both polyphenols and antioxidant compounds, often associated with general metabolic support. In Gluco6, it rounds out the ingredient profile by aligning with consumer interest in traditional, plant-based health strategies rooted in natural formulation integrity. SECTION 5 – USER JOURNEY / MARKET TONE Across digital forums and health-focused communities, the tone surrounding glucose management has increasingly moved away from urgency-based problem-solving and toward long-term lifestyle integration. In this context, Gluco6 has entered the conversation as a formulation that addresses the rising demand for informational tools and ingredient-based pathways to support blood sugar regulation. Public sentiment reveals a clear preference for products that avoid medicalized language, instead offering educational framing around metabolic function and ingredient transparency. Online discussions often express skepticism toward claims of immediate results or radical transformations. In contrast, formulas like Gluco6 that focus on metabolic alignment, ingredient sourcing, and mechanistic clarity tend to resonate with individuals seeking research-informed guidance. As part of this narrative, Gluco6 has become associated with keywords such as 'GLUT-4 support,' 'non-synthetic blood sugar wellness,' and 'plant-based glucose solutions.' These search behaviors suggest a broader move toward exploring biological systems—such as cellular glucose transport—in a non-clinical but scientifically aware manner. Consumers participating in wellness forums frequently reference the desire to feel more in control of their day-to-day energy levels and post-meal stability without pharmacological dependency. They often describe searching for products that offer complementary nutritional pathways they can adopt over the long term. Gluco6's tone—deliberately positioned to inform rather than promote—mirrors this mindset. The formula's emphasis on education and lifestyle compatibility aligns with current consumer values, which prioritize sustainability, body literacy, and autonomy in health decisions. While public reactions are diverse and nuanced, the ongoing dialogue reflects a collective interest in approaching metabolic balance through mechanisms that are well-researched, naturally derived, and openly documented. Those interested in understanding the formulation's alignment with non-synthetic wellness trends can refer to the official Gluco6 platform. SECTION 6 – AVAILABILITY AND TRANSPARENCY STATEMENT Gluco6 is available exclusively through its official informational platform, where consumers can explore the full ingredient list, formulation philosophy, and supporting research references. The company has stated that its distribution strategy is designed to prioritize transparency, quality control, and educational alignment with its wellness-focused mission. The formulation, which includes plant-based compounds and mineral co-factors, is intended as a non-clinical support system for individuals seeking to understand the connection between nutrition and blood sugar balance. Gluco6's online resource hub outlines the formulation's alignment with current interest in GLUT-4 receptor mechanisms and clean-label supplement design. Gluco6 is not marketed for diagnosis, treatment, or disease prevention. Its availability is framed around informed decision-making and consumer curiosity about integrative approaches to glucose metabolism. Those exploring the official site will find detailed sourcing disclosures and links to peer-reviewed literature, reinforcing the company's commitment to a research-informed, educational-first posture. SECTION 7 – FINAL OBSERVATIONS & INDUSTRY CONTEXT The release of Gluco6's updated 2025 positioning illustrates a wider shift in the nutraceutical sector toward clean-label transparency and biologically aligned formulation strategies. As consumers become more literate in the language of metabolism and glucose regulation, there is growing demand for products that reflect an understanding of cellular mechanisms—such as GLUT-4 receptor function—without resorting to exaggerated claims or clinical positioning. Within this evolving landscape, companies that emphasize ingredient integrity, sustainability, and scientific relevance are seeing greater engagement. The industry is increasingly guided by consumer expectations around education-first marketing, non-synthetic ingredient profiles, and sourcing disclosures. These trends are mirrored by increased online traffic for topics like 'natural blood sugar solutions,' 'plant-based glucose support,' and 'glucose metabolism supplements.' Gluco6's 2025 formulation strategy aligns with this new model of supplement development, in which consumer trust is cultivated through clarity, research alignment, and responsible communication. Rather than framing its product as a solution to a medical problem, the company presents Gluco6 as part of an ongoing exploration into how nutrition science can support the body's innate regulatory systems. This approach reflects an industry-wide trend: prioritizing science-backed, naturally derived compounds that integrate into everyday routines without overstating function. As consumer literacy deepens and regulatory scrutiny increases, Gluco6 represents one example of how wellness-aligned products are adapting to new expectations in both content and delivery. SECTION 8 – PUBLIC COMMENTARY THEME SUMMARY In ongoing public forums and digital health communities, Gluco6 has emerged as part of a broader conversation around non-synthetic blood sugar support, drawing a range of responses that highlight both interest and scrutiny. Among recurring discussion points, many participants have noted the formula's focus on GLUT-4 receptor pathways as a distinguishing element, particularly given the increasing awareness around cellular glucose transport in metabolic wellness contexts. Some users have expressed curiosity about the inclusion of lesser-known compounds such as Sukre™, citing interest in how this ingredient fits into emerging nutritional science. Others have pointed to the presence of familiar ingredients—like Cinnamon, Chromium, and Green Tea—as aligning with existing wellness preferences for natural, food-based compounds. A recurring theme in positive commentary centers around the non-stimulant profile of the formula. Consumers who prioritize energy regulation without caffeine or dependency have referenced this as a potential alignment with their values. Transparency in ingredient sourcing and documentation has also been identified as a favorable trait, especially among those seeking clarity in wellness product selection. At the same time, some public sentiment remains cautiously observational. Individuals exploring glucose support options often raise questions about long-term integration, expected timelines for perceived effects, and how formulas like Gluco6 should be interpreted within the context of dietary and lifestyle change. This underscores a broader pattern in health discussions—where skepticism and education coexist as consumers navigate an increasingly complex wellness market. These public conversations reflect a nuanced reception that values transparency, biological alignment, and clear communication. While interest in the GLUT-4 mechanism is growing, the broader dialogue continues to emphasize the importance of framing nutritional products as part of a holistic, informed approach to metabolic balance. ABOUT THE COMPANY Gluco6 was developed as part of a broader initiative to provide consumers with transparent, research-aligned nutritional formulas focused on metabolic wellness. The company's mission is to support individuals seeking non-synthetic pathways to manage energy, blood sugar stability, and overall well-being through informed supplementation. By emphasizing ingredient traceability, scientific context, and clean-label formulation practices, Gluco6 contributes to a growing category of supplements positioned at the intersection of education and daily health support. The company does not offer medical advice or therapeutic services and does not market its products for the treatment, prevention, or diagnosis of disease. Its offerings are intended for informational and wellness-aligned purposes only. CONTACT: Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
CBS News
5 hours ago
- CBS News
NASA finds new interstellar comet passing through solar system
NASA has discovered a new interstellar comet that's currently located about 420 million miles away from Earth. The space agency spotted the quick-moving object with the Atlas telescope in Chile on Tuesday and confirmed it was a comet from another star system. The new interstellar comet's official name is 3I/ATLAS. It's officially the third known interstellar object to pass through our solar system, and it poses no threat to Earth. The other two interstellar objects were 2I/Borisov, reported in 2019, and Oumuamua in 2017. This diagram provided by NASA/JPL-Caltech shows the trajectory of interstellar comet 3I/ATLAS as it passes through the solar system. NASA "These things take millions of years to go from one stellar neighborhood to another, so this thing has likely been traveling through space for hundreds of millions of years, even billions of years," Paul Chodas, director of NASA's Center for Near Earth Object Studies, said Thursday. "We don't know, and so we can't predict which star it came from." The newest visitor is 416 million miles from the sun, out near Jupiter, and heading this way at a blistering 37 miles per second. NASA said the comet will make its closest approach to the sun in late October, scooting between the orbits of Mars and Earth — but closer to the red planet than Earth at a safe 150 million miles away. Astronomers around the world are monitoring the icy snowball that's been officially designated as 3I/Atlas to determine its size and shape. Chodas told The Associated Press there have been more than 100 observations since its discovery, with preliminary reports of a tail and a cloud of gas and dust around the comet's nucleus. NASA said 3I/ATLAS should remain visible to telescopes through September, but then it will pass too close to the sun to observe. It is expected to reappear on the other side of the sun by early December, allowing for renewed observations. Based on its brightness, the comet appears to be bigger than the first two interstellar interlopers, possibly several miles across, Chodas said. It's coming in faster, too, from a different direction, and while its home star is unknown, scientists suspect it was closer to the center of our Milky Way galaxy. "We've been expecting to see interstellar objects for decades, frankly, and finally we're seeing them," Chodas said. "A visitor from another solar system, even though it's natural — it's not artificial, don't get excited because some people do ... It's just very exciting."
Gizmodo
6 hours ago
- Gizmodo
Lost in Space: A ‘Game-Changing' Emissions Satellite Just Went Dark
An $88 million satellite backed by billionaire Jeff Bezos is lost in space. MethaneSAT, designed to sniff out sources of methane emissions across the globe, only survived about 15 months in Earth's orbit before meeting its untimely end. The Environmental Defense Fund (EDF), which launched the satellite in March 2024, announced its demise on July 1. The organization revealed that MethaneSAT suddenly went silent on June 20, and its mission operations team has been unable to re-establish contact ever since. Now, they believe the satellite has lost power altogether. Steven Hamburg, EDF's chief scientist and leader of the MethaneSAT mission, told Science there was no previous indication of a problem. 'Not one of my better days or weeks,' he said. When MethaneSAT launched, EDF promised it would be a 'game-changer' for tracking planet-warming methane emissions, helping regulators address point sources of this potent greenhouse gas. In some ways, it has been. For over a year, this satellite helped pinpoint industrial sources of methane emissions—primarily those produced by the oil and gas industry. This greenhouse gas is incredibly potent, trapping 28 times more heat in Earth's atmosphere over a 100-year time period than carbon dioxide, according to the Environmental Protection Agency. Experts know methane emissions primarily stem from agriculture, fossil fuel production, and decomposition of landfill waste, but its point sources are difficult to locate and quantify individually. MethaneSAT, developed with the help of a $100 million grant from Jeff Bezos's Earth Fund, aimed to make this easier. While other satellites—such as the European Space Agency's Sentinel-5—can map methane on larger scales, MethaneSAT's state-of-the-art spectrometers could detect smaller emissions across entire oil and gas fields. At the same time, it zeroed in on hot spots with unprecedented precision, producing high-resolution snapshots of methane 'leaks.' 'Thanks to MethaneSAT, we have gained critical insight about the distribution and volume of methane being released from oil and gas production areas,' the EDF statement reads. 'We have also developed an unprecedented capability to interpret the measurements from space and translate them into volumes of methane released. This capacity will be valuable to other missions.' Still, it's a huge bummer that MethaneSAT's operational days are over. This satellite was supposed to survive five years in orbit, circling the Earth 15 times per day to produce a wealth of freely available, near-real-time data. This would have made tracking and regulating emissions much easier for both companies and regulators. The data would also have been available to stakeholders, including citizens, governments, investors, and gas importers. EDF hopes the satellite's legacy will live on. 'EDF and MethaneSAT remain firmly committed to our core purpose of turning data into action to protect the climate, including reducing methane emissions from the global oil and gas industry,' the organization stated. EDF will continue processing the data it has retrieved from the satellite, with plans to release additional images of regional-scale methane emissions from fossil fuel production over the coming months. The group will also work with global partners to leverage the algorithms and associated software built to convert its observations into emissions estimates, as well as its high-precision technology. Other satellites could make use of these assets to fill in the gap MethaneSAT left behind. EDF has not shared plans to launch another satellite. 'We're going to take a pause,' Hamburg told Science. 'Obviously, we've suffered a loss,' he said. 'I have a large team of people who have put their heart and soul into what many people said was impossible.' Hopefully, MethaneSAT's successes encourage other innovators to continue its mission. 'To solve the climate challenge requires bold action and risk-taking and this satellite was at the leading edge of science, technology, and advocacy,' EDF stated.
